Sumitomo Chemical Limite... (SOMMY)
OTC: SOMMY
· Real-Time Price · USD
16.43
0.26 (1.61%)
At close: Oct 03, 2025, 3:27 PM
16.17
-1.55%
After-hours: Oct 01, 2025, 08:00 PM EDT
Sumitomo Chemical Income Statement
Financials in JPY. Fiscal
year is
April - March.
| Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 2,520.3B | 2,606.3B | 2,544.9B | 2,501.4B | 2,495.9B | 2,446.9B | 2,445.1B | 2,553.6B | 2,684.3B | 2,895.3B | 2,984.5B | 2,968.7B | 2,900.5B | 2,765.3B | 2,682.2B | 2,565.4B | 2,425.8B | 2,287B | 2,217.7B | 2,165B | 2,172.8B |
Cost of Revenue | 1,802.9B | 1,880.8B | 1,920.5B | 1,907.8B | 1,953.5B | 1,947.2B | 1,899.4B | 1,953.5B | 1,980B | 2,074.4B | 2,094.6B | 2,069.1B | 1,990.9B | 1,891.5B | 1,803.4B | 1,706.4B | 1,623B | 1,515.8B | 1,468.5B | 1,447.5B | 1,465.8B |
Gross Profit | 717.34B | 725.48B | 624.35B | 593.58B | 542.4B | 499.69B | 545.7B | 600.08B | 704.27B | 820.93B | 889.88B | 899.61B | 909.55B | 873.86B | 878.89B | 859.03B | 802.74B | 771.2B | 749.22B | 717.49B | 706.95B |
Operating Income | 135.62B | 121.67B | -207.02B | -244.62B | -344.94B | -428.18B | -249.51B | -225.23B | -169.01B | -30.98B | 88.52B | 131.3B | 222.94B | 215B | 218.39B | 230.61B | 176.7B | 137.12B | 126.5B | 85.75B | 93.9B |
Interest Income | n/a | 40.16B | 78.62B | 86.19B | 104.22B | 103.22B | 80.67B | 81.94B | 93.75B | 116.48B | 133.25B | 139.35B | 118.24B | 59.42B | 42.24B | 29.98B | 22.68B | 24.36B | 11.66B | 17.09B | 18.32B |
Pretax Income | 26.43B | 58.09B | -262.77B | -389.54B | -375.45B | -462.79B | -254.49B | -230.34B | -163.29B | 231M | 136.37B | 231.13B | 308.1B | 251.14B | 253.84B | 245.74B | 180.63B | 137.8B | 97.21B | 72.68B | 87.47B |
Net Income | 9.69B | 38.59B | -173.48B | -242.02B | -254.3B | -311.84B | -163.1B | -150.42B | -96.16B | 6.99B | 88.78B | 154.31B | 196.46B | 162.13B | 157.77B | 135.46B | 87.33B | 44.92B | 14.15B | -445M | 9.63B |
Selling & General & Admin | 583.46B | 601.07B | 514.07B | 538.24B | 560.33B | 587.17B | 532.83B | 558.41B | 638.54B | 656.45B | 683.3B | 660.63B | 577.53B | 547.1B | 523.19B | 501.57B | 474.41B | 455.12B | 468.29B | 466.52B | 460.22B |
Research & Development | n/a | n/a | 44.56B | 88.66B | 88.66B | 134.16B | 139.88B | 143.28B | 143.28B | 144.08B | 141.02B | 134.42B | 177.22B | 171.92B | 174.45B | 133.55B | 90.75B | 49.75B | 174.3B | 174.3B | 174.3B |
Other Expenses | -1.74B | 2.73B | 17.35B | -43.92B | -16.87B | -25.98B | -25.98B | 17.95B | -14.22B | -14.22B | -14.22B | -14.22B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 581.72B | 603.8B | 575.98B | 582.98B | 632.12B | 660.62B | 763.78B | 776.59B | 824.56B | 827.9B | 805.79B | 795.93B | 726.72B | 701.04B | 703.28B | 666.17B | 641.63B | 621.62B | 590.25B | 605.79B | 600.73B |
Interest Expense | n/a | 14.18B | 27.29B | 64.06B | 74.08B | 77.19B | 72.1B | 87.05B | 88.02B | 85.27B | 85.4B | 39.52B | 33.08B | 23.29B | 15.14B | 23.55B | 27.46B | 32.38B | 41.32B | 30.16B | 24.75B |
Selling & Marketing Expenses | 104.69B | 104.69B | -299.95B | -299.95B | -299.95B | -299.95B | 150.03B | 150.03B | 150.03B | 150.03B | 119.14B | 119.14B | 119.14B | 119.14B | 100.85B | 100.85B | 100.85B | 100.85B | 99.35B | 99.35B | 99.35B |
Cost & Expenses | 2,384.7B | 2,484.6B | 2,751.9B | 2,746.2B | 2,841B | 2,863.2B | 2,663.2B | 2,730.1B | 2,804.6B | 2,902.3B | 2,900.4B | 2,865B | 2,717.6B | 2,592.5B | 2,506.6B | 2,372.6B | 2,264.7B | 2,137.4B | 2,058.7B | 2,053.3B | 2,066.6B |
Income Tax Expense | 13.75B | 15.4B | -2.96B | -10.85B | 4.93B | 2.66B | -985M | -3.37B | 19.87B | 47.1B | 63.9B | 79.44B | 75.44B | 64.7B | 84.23B | 85.28B | 75.62B | 69.73B | 55.2B | 52.94B | 51.51B |
Shares Outstanding (Basic) | 327.3M | 327.68M | 327.21M | 327.19M | 327.29M | 327.19M | 327.07M | 327.06M | 327.04M | 327.07M | 326.99M | 326.99M | 326.99M | 326.99M | 327M | 327M | 327M | 327M | 327M | 327M | 327M |
Shares Outstanding (Diluted) | 327.3M | 327.69M | 327.19M | 327.19M | 327.29M | 327.19M | 327.07M | 327.06M | 327.04M | 327.07M | 326.99M | 326.99M | 326.99M | 326.99M | 327M | 327M | 327M | 327M | 327M | 327M | 327M |
EPS (Basic) | 29.65 | 117.95 | -530.2 | -739.7 | -777.3 | -953.15 | -498.65 | -459.9 | -294 | 21.40 | 271.50 | 471.90 | 600.80 | 495.80 | 482.45 | 414.20 | 267.05 | 137.35 | 43.30 | -1.35 | 29.45 |
EPS (Diluted) | 29.60 | 117.90 | -530.2 | -739.7 | -777.3 | -953.15 | -498.65 | -459.9 | -294 | 21.40 | 271.50 | 471.90 | 600.80 | 495.80 | 482.45 | 414.20 | 267.05 | 137.35 | 43.30 | -1.45 | 29.25 |
EBITDA | 306.57B | 303.99B | -37.42B | -95.12B | -172.38B | -255.21B | -80.72B | -30.84B | 39.95B | 157.67B | 289.44B | 307.06B | 354.39B | 338.23B | 317.27B | 332.2B | 284.92B | 259.17B | 283.32B | 232.04B | 235.24B |
EBIT | 178.82B | 172.39B | -176.94B | -235B | -318.37B | -379.8B | -176.59B | -143.29B | -75.27B | 85.5B | 221.77B | 270.65B | 341.18B | 274.42B | 256.14B | 255.81B | 194.3B | 156.11B | 137.29B | 102.25B | 111.93B |
Depreciation & Amortization | 127.75B | 131.6B | 139.52B | 145.68B | 151.79B | 157.52B | 158.27B | 160.79B | 163.54B | 167.96B | 166.76B | 164.79B | 162.81B | 156.67B | 155.03B | 149.27B | 142.28B | 136.89B | 132.22B | 131.65B | 131.78B |